Regional Regulatory Affairs Director
ZP Therapeutics, a Division of Zuellig Pharma
Fazlin Azura Azlan is Director, Regional Regulatory Affairs for Zuellig Pharma who partners with multinational pharmaceutical and healthcare organizations in bringing in innovative healthcare products into Asia Pacific through strategic regulatory channels.
After spending 2 decades working in regulatory affairs of healthcare products covering Malaysia and other Asia Pacific (APAC) countries, Fazlin knows what is essential to bridge the gaps between requirement of different developing nations in APAC and available data from various organizations all over the world. Her ultimate career goal is to facilitate fast accessibility of new innovative healthcare products from developed nations to patients in APAC countries.
In her career with Zuellig Pharma she has set up the regulatory and pharmacovigilance division within the regional headquarter and led the regulatory division for Zuellig Pharma in all its 13 territories in ASIA. The regulatory team has now expanded to more than 30 regulatory officers across all the territories covering over 3000 Marketing Authorizations. The regulatory division has been successful in strategizing, developing and implementing registration plans to accelerate access to innovative healthcare products in Asia and will continue to strive in providing the best regulatory strategy for access to Asia.
Disclosure information not submitted.
Monday, September 12, 2022
9:45 AM – 11:00 AM MST
Monday, September 12, 2022
11:15 AM – 11:45 AM MST